CLOCORTOLONE PIVALATE
CLOCORTOLONE PIVALATE is indicated for the treatment of Dermatoses.
Details
- Status
- Prescription
- First Approved
- 2020-04-21
- Routes
- TOPICAL
- Dosage Forms
- CREAM
CLOCORTOLONE PIVALATE Approval History
What CLOCORTOLONE PIVALATE Treats
1 indicationsCLOCORTOLONE PIVALATE is approved for 1 conditions since its original approval in 2020. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Dermatoses
CLOCORTOLONE PIVALATE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to CLOCORTOLONE PIVALATE
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04358770 | CLPC-1801 | Ph 1 | completed | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CLOCORTOLONE PIVALATE FDA Label Details
Indications & Usage
CLOCORTOLONE PIVALATE is indicated for the treatment of Dermatoses.
Looking for the branded version?
CLODERM
Full clinical data, patents, trials, and competitive landscape for clocortolone pivalate.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.